Clear Harbor Asset Management LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 42,883 shares of the company’s stock, valued at approximately $5,511,000.
Other institutional investors have also made changes to their positions in the company. Davis Asset Management L.P. acquired a new position in Merck KGaA during the 2nd quarter worth about $514,000. First Nebraska Trust Co acquired a new stake in Merck KGaA in the 2nd quarter valued at about $13,382,000. Bank of Nova Scotia acquired a new stake in Merck KGaA in the 2nd quarter valued at about $281,696,000. Kendall Capital Management bought a new position in shares of Merck KGaA in the second quarter worth about $2,529,000. Finally, Vista Investment Management acquired a new position in shares of Merck KGaA during the second quarter worth approximately $385,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Price Performance
Shares of MKGAF stock opened at $163.21 on Friday. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm’s 50 day moving average is $162.62 and its 200-day moving average is $148.46. The firm has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
